Adda Nathalie

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
14
Insider Sells Sum
$12.93M

Insider Activity of Adda Nathalie

The largest sale of all time was on 2022-03-01 and amounted to 24339 shares of Enanta Pharmaceuticals, Inc. for $1.71M.

Biography of Adda Nathalie

No biography is available at this moment.

2022-04-01SaleEnanta Pharmaceuticals, Inc.
ENTA
Sr. VP & Chief Medical Officer
18,076
0.0872%
$71.71$1.3M-31.68%
2022-03-02SaleEnanta Pharmaceuticals, Inc.
ENTA
Sr. VP & Chief Medical Officer
12,481
0.0609%
$70.07$874,544-27.8%
2022-03-01SaleEnanta Pharmaceuticals, Inc.
ENTA
Sr. VP & Chief Medical Officer
24,339
0.1193%
$70.26$1.71M-27.55%
2022-01-11SaleEnanta Pharmaceuticals, Inc.
ENTA
Sr. VP & Chief Medical Officer
12,536
0.0606%
$70.13$879,150-25.4%
2021-12-01SaleEnanta Pharmaceuticals, Inc.
ENTA
Sr. VP & Chief Medical Officer
13,523
0.068%
$86.35$1.17M-29.88%
2021-11-01SaleEnanta Pharmaceuticals, Inc.
ENTA
Sr. VP & Chief Medical Officer
9,547
0.0467%
$84.89$810,419-25.93%
2021-10-11SaleEnanta Pharmaceuticals, Inc.
ENTA
Sr. VP & Chief Medical Officer
4,047
0.0197%
$70.34$284,685-8.38%
2021-10-08SaleEnanta Pharmaceuticals, Inc.
ENTA
Sr. VP & Chief Medical Officer
13,453
0.066%
$70.09$942,934-6.92%
2018-09-20SaleEnanta Pharmaceuticals, Inc.
ENTA
Sr. VP & Chief Medical Officer
8,310
0.0418%
$95.32$792,072-16.05%
2018-08-20SaleEnanta Pharmaceuticals, Inc.
ENTA
Sr. VP & Chief Medical Officer
8,310
0.0438%
$92.32$767,192-5.76%
2018-07-18SaleEnanta Pharmaceuticals, Inc.
ENTA
Sr. VP & Chief Medical Officer
8,310
0.0427%
$125.09$1.04M-29.8%
2018-06-18SaleEnanta Pharmaceuticals, Inc.
ENTA
Sr. VP & Chief Medical Officer
8,310
0.0434%
$114.85$954,444-20.91%
2018-05-16SaleEnanta Pharmaceuticals, Inc.
ENTA
Sr. VP & Chief Medical Officer
8,310
0.034%
$83.17$691,139-14.04%
2018-04-16SaleEnanta Pharmaceuticals, Inc.
ENTA
Sr. VP & Chief Medical Officer
8,450
0.0436%
$85.58$723,119+6.54%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.